Sirtuin deacetylases in neurodegenerative diseases of aging.
about
Hyperglycemic Stress and Carbon Stress in Diabetic GlucotoxicityResveratrol: A Focus on Several Neurodegenerative DiseasesMitochondrial targets for pharmacological intervention in human diseaseSirtuins in epigenetic regulationActivation of SIRT3 by the NAD⁺ precursor nicotinamide riboside protects from noise-induced hearing lossOptimal therapy of type 2 diabetes: a controversial challengeLack of synergistic effect of resveratrol and sigma-1 receptor agonist (PRE-084) in SOD1G⁹³A ALS mice: overlapping effects or limited therapeutic opportunity?Dissecting the Molecular Mechanisms of Neurodegenerative Diseases through Network BiologyIs SIRT6 Activity Neuroprotective and How Does It Differ from SIRT1 in This Regard?A Chemical Biology Approach to Reveal Sirt6-targeted Histone H3 Sites in Nucleosomes.Regulation of NAD+ metabolism, signaling and compartmentalization in the yeast Saccharomyces cerevisiaeThe Molecular Mechanism of Amyloid β42 Peptide Toxicity: The Role of Sphingosine Kinase-1 and Mitochondrial SirtuinsAcetylome Analysis Identifies SIRT1 Targets in mRNA-Processing and Chromatin-Remodeling in Mouse Liver.CAMKII-conditional deletion of histone deacetylase 2 potentiates acute methamphetamine-induced expression of immediate early genes in the mouse nucleus accumbens.PGC-1α/ERRα-Sirt3 Pathway Regulates DAergic Neuronal Death by Directly Deacetylating SOD2 and ATP Synthase β.High glucose-induced oxidative stress represses sirtuin deacetylase expression and increases histone acetylation leading to neural tube defectsIdentification of sirtuin 1 as a promising therapeutic target for hypertrophic scars.p53-dependent SIRT6 expression protects Aβ42-induced DNA damage.Changes in brain oxysterols at different stages of Alzheimer's disease: Their involvement in neuroinflammationThe phasor-FLIM fingerprints reveal shifts from OXPHOS to enhanced glycolysis in Huntington DiseaseCalorie restriction and sirtuins revisitedSIRT6 delays cellular senescence by promoting p27Kip1 ubiquitin-proteasome degradation.Turn up the power - pharmacological activation of mitochondrial biogenesis in mouse models.Resveratrol improves motoneuron function and extends survival in SOD1(G93A) ALS mice.Role of Sirt1 during the ageing process: relevance to protection of synapses in the brain.Role of SIRT1 in autoimmune demyelination and neurodegeneration.Aging and uremia: Is there cellular and molecular crossover?Molecular evolutionary patterns of NAD+/Sirtuin aging signaling pathway across taxa.Nicotinamide Adenine Dinucleotide Metabolism and Neurodegeneration.How does resveratrol influence the genesis of some neurodegenerative diseases?The NAD+ synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream targetCould Sirtuin Activities Modify ALS Onset and Progression?Sirtuins Expression and Their Role in Retinal Diseases.The brain, sirtuins, and ageing.Effects of Resveratrol and Other Polyphenols on Sirt1: Relevance to Brain Function During Aging.SIRT1 inhibition affects angiogenic properties of human MSCsThe Neuroprotective Effects of SIRT1 on NMDA-Induced Excitotoxicity.Sirtuin 2 Deficiency Increases Bacterial Phagocytosis by Macrophages and Protects from Chronic Staphylococcal Infection.Decreased Neuron Number and Synaptic Plasticity in SIRT3-Knockout Mice with Poor Remote Memory.Decreased Sirtuin Deacetylase Activity in LRRK2 G2019S iPSC-Derived Dopaminergic Neurons.
P2860
Q26773988-27A5F465-A602-4D80-9B67-4A51BBAA0C44Q26800952-9D14CB30-1657-4C0D-9F5F-C8670BBC0139Q26824514-5106C011-889D-413E-B32C-ADAFBAD1C408Q27026861-B84EF21E-091E-40BA-9404-F656394BB013Q27318173-06C60486-5C41-4229-A4EC-38E8C4AC59BFQ33577712-95C7A781-1A16-43A4-BA09-93DE1A064207Q33673677-0CDBB685-F9B6-4F5A-B2B9-F7479CF62167Q33734563-45F7423F-3855-419E-9D2C-94E1A908866CQ33774831-DF3BC962-AF45-4405-9AAE-86F68FC6348FQ33817548-0A8492CC-3F1C-49AC-97AC-7C9AD1D2DCECQ34622726-53CA99DA-5F73-4B65-8CA7-2B68E76F2496Q35763022-64141D43-E448-4746-849C-A8BDAEA47F4AQ35808089-09E16C4E-D313-477A-845C-3A63C4F5AE86Q35989524-35577F3F-6477-4B0C-A5FF-393B2E69FC8EQ36602023-35310ECC-E310-4EF3-8572-DB548E1C54AEQ36813699-34BADC2B-2872-4F2A-8C3B-FC058CF96D52Q36830137-AAD7BE05-FD35-4BE5-AC8A-A8026D0CC9ACQ36882294-146C8DAC-5CA4-4D54-9715-AD7AA6218C6BQ37293041-8F9F4123-7C16-455C-BC78-A071DF91D78BQ37319246-1ECA4090-B355-4DDC-9942-31D7FCE024EBQ37362543-50A13F98-56E2-44A2-A303-9EE9377B3AF3Q37423517-9241DAF5-902D-4F56-BC59-8A7BDA5CD81CQ37686240-2E83CD65-E7DA-44EF-B48B-B25D972B8EAFQ37717433-6899766F-9A77-4450-94C6-CA3F8162BC03Q38185276-B49DBDFB-98A0-4A22-B79B-8AB1F9DC7312Q38256576-30FB5D08-6608-40E5-ADD5-BC974721D87DQ38348935-71555B7A-531A-45B6-8C87-ADDF4E1EC39DQ38646652-F64A6B7A-6B92-4117-B106-A3C1D111F785Q38678550-4BB7DDBA-5CF1-442E-9522-994225E2AD5FQ38717050-4033C492-1E9B-4B93-A78A-ECE2C036F6C3Q38717667-2F8F1190-F532-4BF9-971E-6C4A1DB18EC4Q39036105-260BDCF6-80B9-4F3D-AA11-376CD886349DQ39135669-1A7FE06E-C73F-463F-87C2-A0D8EFC4EFA3Q39313687-7C8D587D-3E0E-4CF4-8686-FE8BB1D6F7B9Q39413673-E4C6E9D6-4CE4-4846-8CD4-D5284ECF6D54Q41964604-4CC7A711-DCEA-414D-B430-1FD70B31479AQ42723966-6DBA6EAC-AB4F-4683-9ADB-DC0A603DF08BQ47105213-5DB6891B-BD5E-485E-AE07-CDFB4AA95144Q47596886-F9496535-661D-4BB6-AA08-18CD9C7D474EQ47611066-B8B57C13-B99D-48B2-9285-963341C124FC
P2860
Sirtuin deacetylases in neurodegenerative diseases of aging.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Sirtuin deacetylases in neurodegenerative diseases of aging.
@en
type
label
Sirtuin deacetylases in neurodegenerative diseases of aging.
@en
prefLabel
Sirtuin deacetylases in neurodegenerative diseases of aging.
@en
P2860
P356
P1433
P1476
Sirtuin deacetylases in neurodegenerative diseases of aging.
@en
P2093
Adrianna Z Herskovits
Leonard Guarente
P2860
P2888
P304
P356
10.1038/CR.2013.70
P5008
P577
2013-05-21T00:00:00Z
2013-06-01T00:00:00Z